Search - tctmd.com

Displaying 1 - 20 of 498

Sort: Relevancy | Date

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

Caitlin E. Cox

December 04, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Conference News AHA 2025

Beta-blockers Not Helpful After MI in Patients With Preserved EF

Yael L. Maxwell

November 12, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Caitlin E. Cox

October 16, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Daily News

Recognize and Enable Care for Post-MI Psychological Distress: AHA

L.A. McKeown

October 01, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Daily News

European Experts Provide Advice on Managing CV Effects of COVID-19

Todd Neale

September 19, 2025

News Conference News ESC 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

L.A. McKeown

September 09, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

Advertisement

Frailty Extra Risky in Young Patients With Acute MI

November 2025 Dispatch for the CV Team

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Beta-blockers Not Helpful After MI in Patients With Preserved EF

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

What’s Going to Be Hot at TCT 2025

Risk Factors Present in Nearly All Patients Who Develop CVD

Recognize and Enable Care for Post-MI Psychological Distress: AHA

CVD Still the Leading Cause of Death and Disease Globally

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

European Experts Provide Advice on Managing CV Effects of COVID-19

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

What’s Going to Be Hot at ESC Congress 2025?

August 2025 Dispatch for the CV Team

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

July 2025 Dispatch for the CV Team

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content